MAPK8 and acute myeloid leukemia: Interestingly, the activity of c-Jun N-terminal kinase (JNK), which is found constitutively activated in most patients with acute myeloid leukemia, has been correlated with a «multidrug» anthracycline resistance [32] and controls fibronectin survival signaling under serum-starvation conditions [33].